1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.4081/reumatismo.2004.89" target="_blank" rel="noreferrer noopener">http://doi.org/10.4081/reumatismo.2004.89</a>
Pages
89–93
Issue
2
Volume
56
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Comparative antiplatelet activity of COX1 NSAIDS versus aspirin, encompassing regimen simplification and gastroprotection: a call for a controlled study.
Publisher
An entity responsible for making the resource available
Reumatismo
Date
A point or period of time associated with an event in the lifecycle of the resource
2004
2004-06
Subject
The topic of the resource
Female; Humans; Male; Middle Aged; Time Factors; Feasibility Studies; Anti-Inflammatory Agents; Drug Combinations; Aspirin/administration & dosage/adverse effects/*therapeutic use; Cyclooxygenase Inhibitors/administration & dosage/adverse effects/*therapeutic use; Diclofenac/administration & dosage/adverse effects/*therapeutic use; Ketoprofen/administration & dosage/adverse effects/therapeutic use; Misoprostol/administration & dosage/adverse effects/*therapeutic use; Naproxen/administration & dosage/adverse effects/therapeutic use; Platelet Aggregation Inhibitors/administration & dosage/adverse effects/*therapeutic use; Stomach/drug effects; Non-Steroidal/administration & dosage/adverse effects/*therapeutic use
Creator
An entity primarily responsible for making the resource
Rothschild B M
Description
An account of the resource
This study was conducted to assess the feasibility of COX1 NSAID substitution for aspirin for preventative therapy related to circulating anticoagulants, as manifest by inhibition of platelet aggregation. There was no difference in platelet aggregation inhibition between aspirin, naproxen, ketoprofen or diclofenac and misoprostol (in combination in the form of Arthrotec). As COX1 NSAIDs appear equivalent in platelet inhibition efficacy to aspirin, therapeutic regimens can be simplified in those individuals who require an NSAID for other problems. Further, despite its short serum halflife, Arthrotec appears as effective as an antiplatelet agent. Controlled, double blind studies of efficacy in blocking clinical events (both cardiovascular and gastrointestinal) are recommended.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.4081/reumatismo.2004.89" target="_blank" rel="noreferrer noopener">10.4081/reumatismo.2004.89</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2004
Anti-Inflammatory Agents
Aspirin/administration & dosage/adverse effects/*therapeutic use
Cyclooxygenase Inhibitors/administration & dosage/adverse effects/*therapeutic use
Diclofenac/administration & dosage/adverse effects/*therapeutic use
Drug Combinations
Feasibility Studies
Female
Humans
Ketoprofen/administration & dosage/adverse effects/therapeutic use
Male
Middle Aged
Misoprostol/administration & dosage/adverse effects/*therapeutic use
Naproxen/administration & dosage/adverse effects/therapeutic use
Non-Steroidal/administration & dosage/adverse effects/*therapeutic use
Platelet Aggregation Inhibitors/administration & dosage/adverse effects/*therapeutic use
Reumatismo
Rothschild B M
Stomach/drug effects
Time Factors